Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2021
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2020
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [3]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NMD Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Zero Leprosy Toolkit
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Ofloxacin - OFLO

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (59)

Subject

  • (-) Ofloxacin - OFLO (60)
  • Rifampicin - RMP (23)
  • Treatment (22)
  • Minocycline - MINO (22)
  • Drug resistance (15)
  • Clarithromycin - CLARI (15)
  • Multi-drug therapy (MDT) (12)
  • Moxifloxacin (6)
  • Dapsone (5)
  • Rifapentine - RPT (3)
  • Diagnosis (1)
  • Complications and reactions (1)
  • Preventive Chemotherapy (PC) (1)

Publication Type

  • Article (56)
  • Full text online (31)
  • Letter to the editor (1)

Author/Contributor

  • Ji B (7)
  • Grosset J H (4)
  • Perani E G (3)
  • Abalos RM (2)
  • Petinom C (2)
  • Gelber RH (2)
  • Grosset J (2)
  • Cambau E (2)
  • Cellona RV (2)
  • Matsuoka M (2)
  • Girdhar A (2)
  • Kumar A (2)
  • Lavania M (2)
  • Matsuoka M (2)
  • Sougakoff W (1)
  • Das M (1)
  • Gidoh M (1)
  • Queiroz RHC (1)
  • Malfará WR (1)
  • Lee S (1)
  • Chae G (1)
  • Jarlier V (1)
  • Namisato M (1)
  • Perani E (1)
  • Bonnafous P (1)
  • Dhople AM (1)
  • Bonnafous P (1)
  • Bentoucha A (1)
  • Consigny S (1)
  • Cole ST (1)
  • Natarajan M (1)
  • Arumugam S (1)
  • Kang TJ (1)
  • Cree I A (1)
  • Namba K (1)
  • Cruz EDC (1)
  • Ishikawa M (1)
  • Singh I (1)
  • Yamazaki T (1)
  • Ebenezer M (1)
  • Mukhopadhyay A K (1)
  • Uyemura SA (1)
  • Gunby P (1)
  • Balagon MVF (1)
  • You E (1)
  • Kim S (1)
  • Fajardo TT (1)
  • Villahermosa LG (1)
  • McDermott-Lancaster R D (1)
  • Banerjee D K (1)
  • Gupta U D (1)
  • Petinon C (1)
  • Singh O J (1)
  • Saito H (1)
  • Jamet P (1)
  • Dhople A M (1)
  • Decazes J M (1)
  • Kampirapap K (1)
  • Katoch V M (1)
  • Singh H B (1)
  • Manglani P R (1)
  • Revankar C R (1)
  • Rao P S (1)
  • Sekar B (1)
  • Flageul B (1)
  • Pai V V (1)
  • Ganapati R (1)
  • Sharma V D (1)
  • Subramanian M (1)
  • Arif M A (1)
  • Kashiwabara Y (1)
  • Gupte M D (1)
  • Vissa V (1)
  • Pattyn S R (1)
  • Ji B (1)
  • Hagge D (1)
  • Lockwood DN (1)
  • Katoch K (1)
  • Kai M (1)
  • Kingsley S (1)
  • Sampoonachot P (1)
  • Joseph P (1)
  • Tomioka H (1)
  • Veerasubramanian P (1)
  • Gelber R H (1)
  • Sengupta U (1)
  • Das L (1)
  • Bulchand H O (1)
  • Peerapakorn S (1)
  • Walsh G P (1)
  • Miyamoto Y (1)
  • Cruz E C (1)
  • Villahermosa L G (1)
  • Walsh D S (1)
  • Abalos R M (1)
  • Fajardo T T (1)
  • Saunderson PP R (1)
  • Balagon MF (1)
  • Ozaki M (1)
  • López-García L (1)

Journal

  • Acta leprologica (1)
  • American journal of clinical and experimental medicine (1)
  • Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] (1)
  • Antimicrobial agents and chemotherapy (5)
  • Arzneimittel-Forschung (1)
  • Bulletin de la Societe de pathologie exotique (1990) (1)
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (1)
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (1)
  • Clinical pharmacology : advances and applications (1)
  • Computational and structural biotechnology journal (1)
  • European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (1)
  • Indian journal of dermatology, venereology and leprology (1)
  • Indian journal of leprosy (4)
  • Internal medicine (Tokyo, Japan) (1)
  • International journal of antimicrobial agents (1)
  • International journal of dermatology (4)
  • International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association (6)
  • JAMA (1)
  • Journal of cutaneous medicine and surgery (1)
  • Journal of global antimicrobial resistance (2)
  • Journal of the Indian Medical Association (1)
  • Journal of the Medical Association of Thailand = Chotmaihet thangphaet (1)
  • Lancet (London, England) (1)
  • Leprosy review (8)
  • Medecine tropicale : revue du Corps de sante colonial (1)
  • Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association (2)
  • Pharmacotherapy (1)
  • PLOS Neglected Tropical Diseases (1)
  • Revista da Sociedade Brasileira de Medicina Tropical (2)
  • Serbian Journal of Dermatology and Venereology (1)
  • The American journal of tropical medicine and hygiene (1)
  • The Journal of infection (1)
  • The National medical journal of India (1)
  • Tropical Medicine & International Health (1)

Year of Publication

  • 2021 (20)
  • 2020 (1353)
  • 2019 (1198)
  • 2018 (1170)
  • 2017 (1239)
  • 2016 (1373)
  • 2015 (1068)
  • 2014 (893)
  • 2013 (854)
  • 2012 (652)
  • 2011 (597)
  • 2010 (562)
  • 2009 (589)
  • 2008 (550)
  • 2007 (460)
  • 2006 (443)
  • 2005 (443)
  • 2004 (480)
  • 2003 (463)
  • 2002 (389)
  • 2001 (394)
  • 2000 (428)
  • 1999 (443)
  • 1998 (452)
  • 1997 (419)
  • 1996 (412)
  • 1995 (454)
  • 1994 (493)
  • 1993 (477)
  • 1992 (501)
  • 1991 (490)
  • 1990 (511)
  • 1989 (529)
  • 1988 (552)
  • 1987 (504)
  • 1986 (551)
  • 1985 (523)
  • 1984 (496)
  • 1983 (547)
  • 1982 (500)
  • 1981 (440)
  • 1980 (391)
  • 1979 (422)
  • 1978 (347)
  • 1977 (308)
  • 1976 (398)
  • 1975 (331)
  • 1974 (350)
  • 1973 (342)
  • 1972 (315)
  • 1971 (336)
  • 1970 (314)
  • 1969 (286)
  • 1968 (318)
  • 1967 (260)
  • 1966 (281)
  • 1965 (254)
  • 1964 (193)
  • 1963 (145)
  • 1962 (140)
  • 1961 (154)
  • 1960 (175)
  • 1959 (140)
  • 1958 (129)
  • 1957 (168)
  • 1956 (161)
  • 1955 (148)
  • 1954 (147)
  • 1953 (187)
  • 1952 (227)
  • 1951 (205)
  • 1950 (160)
  • 1949 (43)
  • 1948 (88)
  • 1947 (78)
  • 1946 (36)
  • 1945 (9)
  • 1944 (2)
  • 1942 (5)
  • 1941 (1)
  • 1940 (6)
  • 1939 (8)
  • 1938 (8)
  • 1937 (7)
  • 1936 (24)
  • 1935 (6)
  • 1934 (12)
  • 1933 (12)
  • 1932 (7)
  • 1931 (6)
  • 1930 (7)
  • 1929 (11)
  • 1928 (2)
  • 1927 (6)
  • 1926 (8)
  • 1925 (9)
  • 1924 (8)
  • 1923 (2)
  • 1922 (4)
  • 1921 (2)
  • 1920 (4)
  • 1919 (1)
  • 1917 (1)
  • 1916 (2)
  • 1915 (4)
  • 1914 (6)
  • 1913 (2)
  • 1912 (4)
  • 1911 (11)
  • 1910 (6)
  • 1909 (5)
  • 1908 (4)
  • 1907 (1)
  • 1906 (3)
  • 1905 (1)
  • 1904 (4)
  • 1903 (1)
  • 1902 (5)
  • 1901 (2)
  • 1899 (1)
  • 1898 (4)
  • 1897 (4)
  • 1896 (1)
  • 1895 (2)
  • 1893 (2)
  • 1892 (3)
  • 1891 (2)
  • 1890 (7)
  • 1889 (9)
  • 1888 (1)
  • 1886 (1)
  • 1883 (1)
  • 1881 (1)
  • 1880 (1)
  • 1879 (3)
  • 1878 (1)
  • 1877 (3)
  • 1876 (2)
  • 1875 (3)
  • 1874 (1)
  • 1873 (1)
  • 1872 (1)
  • 1870 (4)
  • 1868 (1)
  • 1867 (1)
  • 1866 (1)
  • 1864 (1)
  • 1863 (1)
  • 1861 (1)
  • 1857 (1)
  • 1855 (1)
  • 1847 (1)
  • 1800 (1)
  • 1765 (1)
  • 2 (1)
  • 0 (153)

Language

  • English (50)
  • French (3)
  • Japanese (2)
  • Portuguese (2)
  • Russian (1)

Regional focus

  • Benin (1)
  • Burkina Faso (1)
  • Ethiopia (1)
  • European Region (EUR) (2)
    • France (2)
  • Guinea (1)
  • Madagascar (1)
  • Mali (1)
  • Mozambique (1)
  • Niger (1)
  • Pakistan (1)
  • Region of the Americas (AMR) (3)
    • Brazil (3)
    • Colombia (1)
    • USA (1)
  • South-East Asia Region (SEAR) (6)
    • India (6)
    • Indonesia (2)
    • Myanmar (1)
    • Nepal (2)
  • Western Pacific Region (WPR) (1)
    • China (1)
    • Korea, South – Republic of Korea (1)
    • Philippines (1)
    • Vietnam (1)
  • Yemen (1)

Research Group

  • LRI / Leprosy Research Initiative
  • IDEAL
  • EUR / Field evaluation of novel immunodiagnostic tools (Jan 2015- Dec 2018)
  • SARI Project (2010-2016)
  • KIT / Treatment of Early Neuropathy in Leprosy Trial (TENLEP) (2010-2016)
  • LSHTM / Development & validation severity scale ENL May 2015 - April 2017
  • IDRI / Integration of rapid diagnostic tests to facilitate case management of leprosy (May 2015 - April 2019)
  • AMC / Role of complement system in nerve damage (2011-2014)
  • LUMC / Immunopathology of leprosy, follow up (2011-2015)
  • Enablement / Inclusion of people with physical disabilities in Nepal
  • LWM / Macro and micro epidemiology of leprosy in Cebu
 
Relevance
Date
60 items

Publication

HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae..

Vedithi S, Malhotra S, Skwark M, et al. Computational and structural biotechnology journal. 2020;
Download PDF

Publication

Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India.

Lavania M, Darlong J, Singh I, et al. Journal of global antimicrobial resistance. 2020;
Download PDF

Publication

Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series.

Faust L, Klowak M, MacRae C, et al. Journal of cutaneous medicine and surgery. 2020;

Publication

Treatment of histoid leprosy: a lack of consensus.

Bartos G, Sheuring R, Combs A, et al. International journal of dermatology. 2020;

Publication

Case Report: Multidrug-Resistant Mycobacterium leprae in a Case of Smear-Negative Relapse.

Kamat D, Narang T, Ahuja M, et al. The American journal of tropical medicine and hygiene. 2020;

Publication

Alternative Leprosy Treatment Using Rifampicin Ofloxacin Minocycline (ROM) Regimen – Two Case Reports

Widjaja Y, Djawad K, Amin S, et al. Walter de Gruyter GmbH. Serbian Journal of Dermatology and Venereology. 2019; 11 (3) : 89-93.
Download PDF

Publication

Development of an Assay System for Genotyping Mycobacterium leprae Resistant to Dapsone, Rifampicin, and Ofloxacin

Tanod V, Bela B, Menaldi S, et al. Indian journal of leprosy. 2019; 91 (3) : 185-195.
Download PDF

Publication

Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-2015.

Cambau E, Saunderson P, Matsuoka M, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2018;
Download PDF

Publication

Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study.

Guragain S, Upadhayay N, Bhattarai BM. Clinical pharmacology : advances and applications. 2017;
Download PDF

Publication

Interleukin-12 and Interleukin-4 Levels of Multibacillary Leprosy Patients Before and After Rifampicine Ofloxacine Minocycline Combined Therapy

Budhiani S, Muchtar SV, Amin S. American journal of clinical and experimental medicine . 2017; 5 (4) : 134-137.
Download PDF

Publication

Molecular detection of multi drug resistant Mycobacterium leprae from Indian leprosy patients.

Lavania M, Singh I, Turankar RP, et al. Journal of global antimicrobial resistance. 2017;
Download PDF

Publication

Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy

Joseph P, Ponnaiya J, Das M, et al. Indian journal of leprosy. 2016;
Download PDF

Publication

A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.

Kumar A, Girdhar A, Girdhar BK. Indian journal of dermatology, venereology and leprology. 2015; 81 (4) : 356-62.
Download PDF

Publication

Resistance of M. leprae to Quinolones: A Question of Relativity?

Veziris N, Chauffour A, Escolano S, et al. PLOS Neglected Tropical Diseases. 2013;
Download PDF

Publication

Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.

Legendre DP, Muzny CA, Swiatlo E. Pharmacotherapy Publications. Pharmacotherapy. 2012; 32 (1) : 27-37.

Publication

OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil

Souza Cunha MG, Virmond M, Schettini AP, et al. Leprosy review. 2012; 83 (3) : 261–268.
Download PDF

Publication

A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India.

Girdhar A, Kumar A, Girdhar BK. Leprosy review. 2011; 82 (1) : 46-54.
Download PDF

Publication

Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis

Setia MS, Shinde SS, Jerajani HR, et al. Blackwell Science. Tropical Medicine & International Health. 2011; 16 (12) : 1541–51.
Download PDF

Publication

The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.

Balagon MF, Cellona RV, Abalos RM, et al. Leprosy review. 2010; 81 (1) : 27-33.
Download PDF

Publication

[Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine].

Diniz LM, Catabriga MDS, Souza Filho JB. Revista da Sociedade Brasileira de Medicina Tropical. 2010; 43 (6) : 695-9.
Download PDF

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page Next ›
  • Last page Last »

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • About Infolep
  • Privacy statement
  • FAQ
  • Contact

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2021 Infolep